0,958  0,004  Antineoplastic (lung cancer)
0,908  0,004  Antineoplastic (breast cancer)
0,898  0,003  Antineoplastic (carcinoma)
0,865  0,002  Antineoplastic (squamous cell carcinoma)
0,859  0,009  Transcription factor NF kappa B inhibitor
0,844  0,005  Antineoplastic (colorectal cancer)
0,837  0,005  Antineoplastic (colon cancer)
0,832  0,005  Antihypercholesterolemic
0,825  0,008  Caspase 9 stimulant
0,809  0,004  Tubulin antagonist
0,799  0,005  Prostate cancer treatment
0,807  0,016  Apoptosis agonist
0,775  0,004  Spasmolytic
0,740  0,004  Antineoplastic (multiple myeloma)
0,735  0,010  Antileukemic
0,725  0,005  Antineoplastic (cervical cancer)
0,722  0,009  Chemopreventive
0,713  0,005  Antimitotic
0,701  0,009  Antineoplastic (ovarian cancer)
0,696  0,007  Cytostatic
0,686  0,006  Antineoplastic (non-small cell lung cancer)
0,684  0,005  Hepatic disorders treatment
0,684  0,006  Caspase 3 stimulant
0,699  0,031  Antiinflammatory
0,667  0,008  NOS2 expression inhibitor
0,640  0,004  Hepatoprotectant
0,643  0,009  Antineoplastic (melanoma)
0,631  0,007  Antineoplastic (brain cancer)
0,610  0,008  Antineoplastic (glioma)
0,607  0,005  Antineoplastic (lymphocytic leukemia)
0,588  0,013  Proliferative diseases treatment
0,579  0,029  TNF expression inhibitor
0,555  0,008  CYP3A4 inhibitor
0,549  0,006  Antineoplastic (renal cancer)
0,550  0,008  Antineoplastic (glioblastoma multiforme)
0,567  0,030  Antineoplastic (solid tumors)
0,545  0,013  Nitric oxide antagonist
0,537  0,006  P-glycoprotein inhibitor
0,550  0,028  Antibacterial
0,526  0,006  Muscle relaxant
0,516  0,005  VCAM1 expression inhibitor
0,524  0,019  Antineoplastic (pancreatic cancer)
0,523  0,021  Cytotoxic
0,486  0,004  Beta tubulin antagonist
0,516  0,038  CYP3A4 substrate
0,491  0,014  ICAM1 expression inhibitor
0,489  0,014  Antineoplastic (lymphoma)
0,485  0,022  Antioxidant
0,456  0,005  Liver fibrosis treatment
0,457  0,011  Antineoplastic (sarcoma)
0,446  0,013  Antineoplastic (small cell lung cancer)
0,453  0,022  Antiprotozoal (Leishmania)
0,432  0,009  Topoisomerase II inhibitor
0,435  0,018  Antineoplastic (liver cancer)
0,444  0,028  Carcinogenic
0,431  0,040  5 Hydroxytryptamine release stimulant
0,409  0,020  Antihypertriglyceridemic
0,422  0,034  AR expression inhibitor
0,406  0,031  Sensitization
0,395  0,022  DNA synthesis inhibitor
0,402  0,030  Mutagenic
0,394  0,030  Free radical scavenger
0,415  0,057  Immunosuppressant
0,393  0,047  Antifungal
0,366  0,022  Abortion inducer
0,353  0,012  Protein kinase stimulant
0,369  0,029  Antineoplastic (osteosarcoma)
0,371  0,034  Antipyretic
0,384  0,048  Respiratory analeptic
0,355  0,031  Antineoplastic (endocrine cancer)
0,325  0,004  Alpha tubulin antagonist
0,385  0,070  CYP2C19 inhibitor
0,383  0,069  CYP2C9 substrate
0,336  0,022  Antiviral (Influenza)
0,357  0,053  Apoptosis antagonist
0,302  0,011  Topoisomerase I inhibitor
0,294  0,007  ATPase inhibitor
0,330  0,047  DNA damaging
0,322  0,041  Vasodilator
0,276  0,004  Microtubule formation inhibitor
0,318  0,047  Hypoglycemic
0,282  0,023  Neurotrophic factor enhancer
0,318  0,064  Sodium/bile acid cotransporter inhibitor
0,313  0,059  Teratogen
0,317  0,067  NOS3 expression inhibitor
0,264  0,015  Antifungal enhancer
0,259  0,013  Antineoplastic antibiotic
0,311  0,066  Lipoxygenase inhibitor
0,264  0,026  Melanin inhibitor
0,240  0,005  Antineoplastic alkaloid
0,259  0,025  Lipid peroxidase inhibitor
0,251  0,020  Antineoplastic (bone cancer)
0,291  0,061  Embryotoxic
0,296  0,067  Hypoxia-inducible factor 1 alpha inhibitor
0,296  0,078  Analeptic
0,279  0,061  Antidiabetic symptomatic
0,230  0,021  Antiviral (Hepatitis B)
0,237  0,033  Contraceptive
0,295  0,091  Vasodilator, coronary
0,316  0,113  Antiprotozoal
0,249  0,055  Antiviral (HIV)
0,244  0,057  Antineoplastic enhancer
0,258  0,072  Tumour necrosis factor alpha release inhibitor
0,218  0,041  Antineoplastic (gastric cancer)
0,231  0,058  Sedative
0,215  0,048  Lipocortins synthesis antagonist
0,255  0,088  Antiosteoporotic
0,210  0,043  Antiviral (Herpes)
0,184  0,017  Topoisomerase II alpha inhibitor
0,229  0,065  RNA-directed DNA polymerase inhibitor
0,168  0,014  Ca2+-transporting ATPase inhibitor
0,224  0,072  Antiulcerative
0,197  0,045  Antiviral (Influenza A)
0,258  0,109  Bone diseases treatment
0,241  0,106  CYP1A2 substrate
0,184  0,050  Arachidonic acid antagonist
0,178  0,047  Genotoxic
0,182  0,053  Interleukin 6 antagonist
0,173  0,050  Skeletal muscle relaxant
0,225  0,104  Antineoplastic (bladder cancer)
0,141  0,021  Antibiotic
0,165  0,047  Acetylcholinesterase inhibitor
0,206  0,092  Peptidyltransferase inhibitor
0,127  0,016  ATPase (Vacuolar H+) inhibitor
0,178  0,076  LDLR expression enhancer
0,160  0,063  Hair growth stimulant
0,216  0,120  UGT2B4 substrate
0,136  0,042  Expectorant
0,210  0,122  CYP2C19 substrate
0,099  0,016  Antitreponemal
0,132  0,056  Growth stimulant
0,106  0,032  Inducible nitric-oxide synthase inhibitor
0,168  0,095  UDP-glucuronosyltransferase substrate
0,097  0,024  HIV-1 integrase (Strand Transfer) inhibitor
0,082  0,012  Lipocortins synthesis agonist
0,117  0,047  CDC-like kinase 3 inhibitor
0,153  0,085  UGT2B7 substrate
0,229  0,161  Antiprotozoal (Plasmodium)
0,094  0,028  HIV-1 integrase (3'-Processing) inhibitor
0,176  0,113  Hypolipemic
0,180  0,117  Platelet antagonist
0,123  0,060  Interleukin 1b antagonist
0,100  0,039  Antiviral (Trachoma)
0,079  0,023  Postmenopausal disorders treatment
0,124  0,072  Papain-like protease (SARS coronavirus) inhibitor
0,127  0,082  CC chemokine 6 receptor antagonist
0,116  0,072  Alcohol dehydrogenase substrate
0,187  0,145  Cardioprotectant
0,094  0,053  Actinic keratosis treatment
0,206  0,165  CTGF expression inhibitor
0,101  0,061  Anabolic
0,107  0,068  Electron transport complex I inhibitor
0,057  0,021  Factor III inhibitor
0,062  0,029  Protein 50S ribosomal subunit inhibitor
0,131  0,101  Sigma receptor agonist
0,112  0,087  Cyclooxygenase 3 inhibitor
0,090  0,070  Butyrylcholinesterase inhibitor
0,180  0,161  UGT1A9 substrate
0,123  0,104  Cholinergic
0,087  0,070  Antiviral (Hepatitis A)
0,180  0,164  Transcription factor STAT3 inhibitor
0,047  0,031  Microtubule stabilization
0,091  0,075  UGT2B11 substrate
0,049  0,040  Aldose reductase inhibitor
0,098  0,089  Carcinogenic, group 3
0,027  0,020  Endothelin receptor antagonist
0,090  0,085  DNA intercalator
0,020  0,016  Corticosteroid-like
0,097  0,092  Alkylator
0,136  0,132  UGT2B10 substrate
0,018  0,014  Endothelin B receptor antagonist
0,028  0,025  Glucocorticoid antagonist

